Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-02 Sale | 2023-10-04 9:30 pm | Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer | 1,200,000 | $10.43 | $12,520,990 | 39,377,224 (Direct) | View |
| 2023-10-02 Purchase | 2023-10-04 5:15 pm | Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner | 1,526,316 | $38 | $58,000,008 | 79,805,331 (Direct) | View |
| 2023-09-28 Sale | 2023-10-02 9:05 pm | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 6,896,144 | $11.55 | $79,650,463 | 5,023,787 (Indirect) | View |
| 2023-09-28 Sale | 2023-10-02 9:00 pm | Roivant Sciences Ltd. | ROIV | SVF Investments (UK) Ltd SVF Holdings (UK) LLP SoftBank Vision Fund L.P. SB INVESTMENT ADVISERS (UK) LTD 10% Owner | 10,000,000 | $12.6 | $126,000,000 | 73,031,667 (Indirect) | View |
| 2023-09-28 Sale | 2023-10-02 8:55 pm | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 10,000,000 | $11.55 | $115,500,000 | 5,023,787 (Indirect) | View |
| 2023-09-28 Sale | 2023-10-02 8:43 pm | Roivant Sciences Ltd. | ROIV | QVT Financial LP Director by Deputization 10% Owner | 10,000,000 | $11.55 | $115,500,000 | 5,023,787 (Indirect) | View |
| 2023-09-27 Sale | 2023-09-29 9:30 pm | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 500,000 | $13.02 | $6,510,000 | 14,418,581 (Direct) | View |
| 2023-09-08 Sale | 2023-09-12 9:32 pm | Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer | 106,430 | $12.19 | $1,297,382 | 14,934,997 (Direct) | View |
| 2023-09-08 Sale | 2023-09-12 9:30 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 99,350 | $12.18 | $1,210,083 | 197,950 (Direct) | View |
| 2023-09-05 Sale | 2023-09-07 9:30 pm | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,724 | $12 | $20,688 | 297,300 (Direct) | View |
| 2023-09-01 Sale | 2023-09-06 9:30 pm | Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer | 93,964 | $11.91 | $1,119,341 | 43,985,782 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-22 Other | 2023-11-27 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 16,549 | $8.68 | 577,136 (Direct) | View |
| 2023-11-22 Other | 2023-11-27 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,415 | $8.68 | 195,061 (Direct) | View |
| 2023-11-22 Other | 2023-11-27 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 11,318 | $8.68 | 1,028,751 (Direct) | View |
| 2023-10-30 Other | 2023-11-01 9:39 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,360 | $8.39 | 279,712 (Direct) | View |
| 2023-10-24 Other | 2023-10-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 18,261 | $8.99 | 595,397 (Direct) | View |
| 2023-10-24 Other | 2023-10-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 12,489 | $8.99 | 1,041,240 (Direct) | View |
| 2023-10-24 Other | 2023-10-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,563 | $8.99 | 196,624 (Direct) | View |
| 2022-10-16 Option Award | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 1,594 | $0 | 75,456 (Direct) | View |
| 2023-10-17 Other | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 687 | $10.3 | 75,456 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 2,269 | $0 | 74,976 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 1,226 | $0 | 20,331 (Direct) | View |
| 2023-10-16 Option Award | 2023-10-18 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 1,269 | $0 | 11,358 (Direct) | View |
| 2023-10-02 Exercise | 2023-10-04 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer | 1,200,000 | $3.85 | 39,377,224 (Direct) | View |
| 2023-10-02 Exercise | 2023-10-04 9:30 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer | 1,200,000 | $0 | 39,377,224 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 5:15 pm | N/A N/A | Immunovant Inc. | IMVT | Roivant Sciences Ltd. Director 10% Owner | 4,473,684 | $38 | 79,805,331 (Direct) | View |
| 2023-09-29 Other | 2023-10-03 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,483 | $11.86 | 282,195 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 500,000 | $3.85 | 14,418,581 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 500,000 | $0 | 14,418,581 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 28,411 | $11.5 | 8,226,011 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 53,033 | $6.4 | 8,226,011 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 27,790 | $0 | 8,226,011 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 47,351 | $11.5 | 4,441,820 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 28,411 | $6.4 | 4,441,820 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 17,762 | $0 | 4,441,820 (Direct) | View |
| 2023-09-28 Other | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 10,243 | $12.67 | 4,441,820 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 251,539 | $11.5 | 74,416,678 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 203,798 | $6.4 | 74,416,678 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 119,534 | $0 | 74,416,678 (Direct) | View |
| 2023-09-28 Other | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Ramaswamy Vivek 10% Owner | 61,947 | $12.67 | 74,416,678 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,894 | $11.5 | 276,736 (Direct) | View |
| 2023-09-27 Exercise | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 169 | $0 | 276,736 (Direct) | View |
| 2023-09-28 Other | 2023-09-29 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 92 | $12.67 | 276,736 (Direct) | View |
| 2023-09-22 Other | 2023-09-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric President & COO | 16,416 | $10.19 | 611,813 (Direct) | View |
| 2023-09-22 Other | 2023-09-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,403 | $10.19 | 197,950 (Direct) | View |
| 2023-09-22 Other | 2023-09-26 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Gline Matthew CEO | 11,227 | $10.19 | 1,044,948 (Direct) | View |
| 2023-09-18 Other | 2023-09-20 9:33 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 6,752 | $11.17 | 80,614 (Direct) | View |
| 2023-09-18 Other | 2023-09-20 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 8,703 | $11.17 | 81,410 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 9:31 pm | N/A 2033-09-11 | Roivant Sciences Ltd. | ROIV | Epperly Melissa B Director | 44,420 | $0 | 45,700 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 9:31 pm | N/A 2033-09-11 | Roivant Sciences Ltd. | ROIV | Fitzgerald Meghan Director | 22,271 | $0 | 23,423 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 9:31 pm | N/A 2033-09-11 | Roivant Sciences Ltd. | ROIV | MOMTAZEE JAMES C Director | 44,420 | $0 | 107,209 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 9:31 pm | N/A 2033-09-11 | Roivant Sciences Ltd. | ROIV | Oren Ilan Director | 44,420 | $0 | 108,005 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 9:30 pm | N/A 2033-09-11 | Roivant Sciences Ltd. | ROIV | MANCHESTER KEITH S Director | 44,420 | $0 | 84,602,975 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 9:30 pm | N/A 2033-09-11 | Roivant Sciences Ltd. | ROIV | Gold Daniel Allen Director | 44,420 | $0 | 122,528,337 (Direct) | View |
| 2023-09-08 Exercise | 2023-09-12 9:32 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer | 106,430 | $3.85 | 14,934,997 (Direct) | View |
| 2023-09-08 Exercise | 2023-09-12 9:32 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer | 106,430 | $0 | 14,934,997 (Direct) | View |
| 2023-09-08 Exercise | 2023-09-12 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 99,350 | $6.48 | 197,950 (Direct) | View |
| 2023-09-08 Exercise | 2023-09-12 9:30 pm | N/A 2027-05-21 | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 99,350 | $0 | 197,950 (Direct) | View |
| 2023-09-05 Exercise | 2023-09-07 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,724 | $6.48 | 297,300 (Direct) | View |
| 2023-09-05 Exercise | 2023-09-07 9:30 pm | N/A 2027-05-21 | Roivant Sciences Ltd. | ROIV | Kumar Rakhi Chief Accounting Officer | 1,724 | $0 | 297,300 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-06 9:30 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer | 93,964 | $3.85 | 43,985,782 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-06 9:30 pm | N/A 2032-04-19 | Roivant Sciences Ltd. | ROIV | Venker Eric Chief Operating Officer | 93,964 | $0 | 43,985,782 (Direct) | View |
| 2023-08-29 Other | 2023-09-01 06:01 am | N/A N/A | Roivant Sciences Ltd. | ROIV | Pulik Richard CFO | 2,368 | $11.19 | 284,563 (Direct) | View |
| 2023-08-27 Exercise | 2023-08-29 9:31 pm | N/A 2026-03-31 | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 53,033 | $6.4 | 6,915,954 (Direct) | View |
| 2023-08-27 Exercise | 2023-08-29 9:31 pm | N/A N/A | Roivant Sciences Ltd. | ROIV | Sukhatme Mayukh Pres&Chief Investment Officer | 22,565 | $0 | 6,915,954 (Direct) | View |